• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

Podcast

In this episode, Christopher Bunick, MD, PhD, discusses a paper he recently co-authored, which explores JAK inhibitor safety compared to traditional systemic therapies for atopic dermatitis.

Related Videos
Related Content
Exploring the Relationship Between AD, Psychological Stress, Sleep Disturbances, and Salivary Biomarkers

Exploring the Relationship Between AD, Psychological Stress, Sleep Disturbances, and Salivary Biomarkers

Article
The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients

The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients

Podcast
RPT193 Demonstrates Greater Improvements in Clinical Efficacy Endpoints vs Placebo in Atopic Dermatitis

RPT193 Demonstrates Greater Improvements in Clinical Efficacy Endpoints vs Placebo in Atopic Dermatitis

Article
The Cutaneous Connection: Understanding Age-Approved Therapies in the Atopic Dermatitis Armamentarium

The Cutaneous Connection: Understanding Age-Approved Therapies in the Atopic Dermatitis Armamentarium

Podcast
Navigating the Complexities of Atopic Dermatitis

Navigating the Complexities of Atopic Dermatitis

Article
Treatment With Rademikibart Led to Clinically Meaningful Responses in Patients With Atopic Dermatitis

Treatment With Rademikibart Led to Clinically Meaningful Responses in Patients With Atopic Dermatitis

Article
© 2023 MJH Life Sciences

All rights reserved.